Role of G Protein-Coupled Estrogen Receptor in Digestive System Carcinomas: A Minireview

References

• Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.
   PubMed Web of Science ®Google Scholar
• Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66(2):115–132.
   PubMed Web of Science ®Google Scholar
• Zimmerman MA, Budish RA, Kashyap S, et al. GPER-novel membrane estrogen receptor. Clin Sci. 2016;130(12):1005–1016. doi:10.1042/CS20160114
   PubMed Web of Science ®Google Scholar
• Revankar CM, Cimino DF, Sklar LA, et al. A transmembrane intracellular estrogen receptor mediates rapid cell signaling. Science. 2005;307(5715):1625–1630. doi:10.1126/science.1106943
   PubMed Web of Science ®Google Scholar
• Prossnitz ER, Arterburn JB. International union of basic and clinical pharmacology. XCVII. G Protein–Coupled Estrogen Receptor and its pharmacologic modulators. Pharmacol Rev. 2015;67(3):505–540. doi:10.1124/pr.114.009712
   PubMed Web of Science ®Google Scholar
• Filardo EJ, Thomas P. Minireview: G Protein-Coupled Estrogen Receptor-1, GPER-1: its mechanism of action and role in female reproductive cancer, renal and vascular physiology. Endocrinology. 2012;153(7):2953–2962. doi:10.1210/en.2012-1061
   PubMed Web of Science ®Google Scholar
• Rosenbaum DM, Rasmussen SG, Kobilka BK, et al. The structure and function of G-protein-coupled receptors. Nature. 2009;459(7245):356–363. doi:10.1038/nature08144
   PubMed Web of Science ®Google Scholar
• Filardo EJ, Quinn JA, Bland KI, et al. Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF. Mol Endocrinol. 2000;14(10):1649–1660. doi:10.1210/mend.14.10.0532
   PubMed Web of Science ®Google Scholar
• Bologa CG, Revankar CM, Young SM, et al. Virtual and biomolecular screening converge on a selective agonist for GPR30. Nat Chem Biol. 2006;2(4):207–212. doi:10.1038/nchembio775
   PubMed Web of Science ®Google Scholar
• Dennis MK, Burai R, Ramesh C, et al. In vivo effects of a GPR30 antagonist. Nat Chem Biol. 2009;5(6):421–427. doi:10.1038/nchembio.168
   PubMed Web of Science ®Google Scholar
• Prossnitz ER, Hathaway HJ. What have we learned about GPER function in physiology and disease from knockout mice? J Steroid Biochem Mol Biol. 2015;153:114–126. doi:10.1016/j.jsbmb.2015.06.014
   PubMed Web of Science ®Google Scholar
• Yu T, Cheng H, Ding Z, et al. GPER mediates decreased chemosensitivity via regulation of ABCG2 expression and localization in tamoxifen-resistant breast cancer cells. Mol Cell Endocrinol. 2020;506:110762. doi:10.1016/j.mce.2020.110762
   PubMed Web of Science ®Google Scholar
• Pupo M, Vivacqua A, Perrotta I, et al. The nuclear localization signal is required for nuclear GPER translocation and function in breast Cancer-Associated Fibroblasts (CAFs).. Mol Cell Endocrinol. 2013;376(1–2):23–32. doi:10.1016/j.mce.2013.05.023
   PubMed Web of Science ®Google Scholar
• Yu T, Yang G, Hou Y, et al. Cytoplasmic GPER translocation in cancer-associated fibroblasts mediates cAMP/PKA/CREB/glycolytic axis to confer tumor cells with multidrug resistance.. Oncogene. 2017;36(15):2131–2145. doi:10.1038/onc.2016.370
   PubMed Web of Science ®Google Scholar
• Prossnitz ER, Barton M. The G-protein-coupled estrogen receptor GPER in health and disease. Nat Rev Endocrinol. 2011;7(12):715–726. doi:10.1038/nrendo.2011.122
   PubMed Web of Science ®Google Scholar
• Yu T, Liu M, Luo H, et al. GPER mediates enhanced cell viability and motility via non-genomic signaling induced by 17β-estradiol in triple-negative breast cancer cells. J Steroid Biochem Mol Biol. 2014;143:392–403. doi:10.1016/j.jsbmb.2014.05.003
   PubMed Web of Science ®Google Scholar
• Li Y, Jia Y, Bian Y, et al. Autocrine motility factor promotes endometrial cancer progression by targeting GPER-1. Cell Commun Signal. 2019;17(1):22. doi:10.1186/s12964-019-0336-4
   PubMedGoogle Scholar
• Yan Y, Jiang X, Zhao Y, et al. Role of GPER on proliferation, migration and invasion in ligand-independent manner in human ovarian cancer cell line SKOV3. Cell Biochem Funct. 2015;33(8):552–559. doi:10.1002/cbf.3154
   PubMed Web of Science ®Google Scholar
• Hsu LH, Chu NM, Kao SH. Estrogen, estrogen receptor and lung cancer. Int J Mol Sci. 2017;18(8):1713. doi:10.3390/ijms18081713
   PubMed Web of Science ®Google Scholar
• Lau KM, Ma FMT, Xia JT, et al. Activation of GPR30 stimulates GTP-binding of Gαi1 protein to sustain activation of Erk1/2 in inhibition of prostate cancer cell growth and modulates metastatic properties. Exp Cell Res. 2017;350(1):199–209. doi:10.1016/j.yexcr.2016.11.022
   PubMed Web of Science ®Google Scholar
• Chimento A, Sirianni R, Casaburi I, et al. GPER agonist G-1 decreases adrenocortical carcinoma (ACC) cell growth in vitro and in vivo. Oncotarget. 2015;6(22):19190–19203. doi:10.18632/oncotarget.4241
   PubMedGoogle Scholar
• Hsu LH, Chu NM, Lin YF, et al. G-protein coupled estrogen receptor in breast cancer. Int J Mol Sci. 2019;20(2):306. doi:10.3390/ijms20020306
   PubMed Web of Science ®Google Scholar
• Thomas P, Pang Y, Filardo EJ, et al. Identity of an estrogen membrane receptor coupled to a G protein in human breast cancer cells. Endocrinology. 2005;146(2):624–632. doi:10.1210/en.2004-1064
   PubMed Web of Science ®Google Scholar
• Liu X, Zhu P, Sham KWY, et al. Identification of a membrane estrogen receptor in zebrafish with homology to mammalian GPER and its high expression in early germ cells of the testis. Biol Reprod. 2009;80(6):1253–1261. doi:10.1095/biolreprod.108.070250
   PubMed Web of Science ®Google Scholar
• Lappano R, Rosano C, De Marco P, et al. Estriol acts as a GPR30 antagonist in estrogen receptor-negative breast cancer cells. Mol Cell Endocrinol. 2010;320(1–2):162–170. doi:10.1016/j.mce.2010.02.006
   PubMed Web of Science ®Google Scholar
• Thomas P, Dong J. Binding and activation of the seven-transmembrane estrogen receptor GPR30 by environmental estrogens: a potential novel mechanism of endocrine disruption. J Steroid Biochem Mol Biol. 2006;102(1–5):175–179. doi:10.1016/j.jsbmb.2006.09.017
   PubMed Web of Science ®Google Scholar
• Jacenik D, Cygankiewicz AI, Krajewska WM. The G protein-coupled estrogen receptor as a modulator of neoplastic transformation. Mol Cell Endocrinol. 2016;429:10–18. doi:10.1016/j.mce.2016.04.011
   PubMed Web of Science ®Google Scholar
• Sheng ZG, Huang W, Liu YX, et al. Bisphenol A at a low concentration boosts mouse spermatogonial cell proliferation by inducing the G protein-coupled receptor 30 expression. Toxicol Appl Pharmacol. 2013;267(1):88–94. doi:10.1016/j.taap.2012.12.014
   PubMed Web of Science ®Google Scholar
• Xu S, Yu S, Dong D, et al. G protein-coupled estrogen receptor: a potential therapeutic target in cancer. Front Endocrinol (Lausanne). 2019;10:725. doi:10.3389/fendo.2019.00725
   PubMed Web of Science ®Google Scholar
• Kajta M, Rzemieniec J, Litwa E, et al. The key involvement of estrogen receptor β and G-protein-coupled receptor 30 in the neuroprotective action of daidzein. Neuroscience. 2013;238:345–360. doi:10.1016/j.neuroscience.2013.02.005
   PubMed Web of Science ®Google Scholar
• Maggiolini M, Vivacqua A, Fasanella G, et al. The G protein-coupled receptor GPR30 mediates c-fos up-regulation by 17β-estradiol and phytoestrogens in breast cancer cells. J Biol Chem. 2004;279(26):27008–27016. doi:10.1074/jbc.M403588200
   PubMed Web of Science ®Google Scholar
• Dong WH, Chen JC, He YL, et al. Resveratrol inhibits K v 2.2 currents through the estrogen receptor GPR30-mediated PKC pathway. Am J Physiol Cell Physiol. 2013;305(5):C547–C557. doi:10.1152/ajpcell.00146.2013
   PubMed Web of Science ®Google Scholar
• Chimento A, Casaburi I, Rosano C, et al. Oleuropein and hydroxytyrosol activate GPER/GPR 30‐dependent pathways leading to apoptosis of ER‐negative SKBR 3 breast cancer cells. Mol Nutr Food Res. 2014;58(3):478–489. doi:10.1002/mnfr.201300323
   PubMed Web of Science ®Google Scholar
• Dennis MK, Field AS, Burai R, et al. Identification of a GPER/GPR30 antagonist with improved estrogen receptor counterselectivity. J Steroid Biochem Mol Biol. 2011;127(3–5):358–366. doi:10.1016/j.jsbmb.2011.07.002
   PubMed Web of Science ®Google Scholar
• DeLeon C, Wang HH, Gunn J, et al. A novel GPER antagonist protects against the formation of estrogen-induced cholesterol gallstones in female mice. J Lipid Res. 2020;61(5):767–777. doi:10.1194/jlr.RA119000592
   PubMed Web of Science ®Google Scholar
• Rouhimoghadam M, Lu AS, Salem AK, et al. Therapeutic perspectives on the modulation of G-protein coupled estrogen receptor, GPER, function. Front Endocrinol (Lausanne). 2020;11:877. doi:10.3389/fendo.2020.591217
   Web of Science ®Google Scholar
• Sharma G, Hu C, Staquicini DI, et al. Preclinical efficacy of the GPER-selective agonist G-1 in mouse models of obesity and diabetes. Sci Transl Med. 2020;12:528. doi:10.1126/scitranslmed.aau5956
   Web of Science ®Google Scholar
• Sharma G, Prossnitz ER. G-protein-coupled estrogen receptor (GPER) and sex-specific metabolic homeostasis. Sex and gender factors affecting metabolic homeostasis. Diabetes Obes. 2017;427–453.
   PubMedGoogle Scholar
• Grande F, Occhiuzzi MA, Lappano R, et al. Computational approaches for the discovery of GPER targeting compounds. Front Endocrinol (Lausanne). 2020;11. doi:10.3389/fendo.2020.00517
   Web of Science ®Google Scholar
• Filardo EJ. A role for G-protein coupled estrogen receptor (GPER) in estrogen-induced carcinogenesis: dysregulated glandular homeostasis, survival and metastasis. J Steroid Biochem Mol Biol. 2018;176:38–48. doi:10.1016/j.jsbmb.2017.05.005
   PubMed Web of Science ®Google Scholar
• Brusselaers N, Maret-Ouda J, Konings P, et al. Menopausal hormone therapy and the risk of esophageal and gastric cancer. Int J Cancer. 2017;140(7):1693–1699. doi:10.1002/ijc.30588
   PubMed Web of Science ®Google Scholar
• Chen CL, Kuo MJ, Yen AMF, et al. Gender difference in the association between metabolic factors and hepatocellular carcinoma. JNCI Cancer Spectr. 2020;4(5):pkaa036. doi:10.1093/jncics/pkaa036
   PubMed Web of Science ®Google Scholar
• Rizzo G, Baroni L. Soy, soy foods and their role in vegetarian diets. Nutrients. 2018;10(1):43. doi:10.3390/nu10010043
   PubMed Web of Science ®Google Scholar
• Lu D, Pan C, Ye C, et al. Meta-analysis of soy consumption and gastrointestinal cancer risk. Sci Rep. 2017;7(1):1–14. doi:10.1038/s41598-016-0028-x
   PubMedGoogle Scholar
• Zhou Y, Li Y, Zhou T, et al. Dietary natural products for prevention and treatment of liver cancer. Nutrients. 2016;8(3):156. doi:10.3390/nu8030156
   PubMed Web of Science ®Google Scholar
• Azeem S, Gillani SW, Siddiqui A, et al. Diet and colorectal cancer risk in Asia-a systematic review. Asian Pac J Cancer Prev. 2015;16(13):5389–5396. doi:10.7314/APJCP.2015.16.13.5389
   PubMedGoogle Scholar
• Baralić K, Buha Djordjevic A, Živančević K, et al. Toxic effects of the mixture of phthalates and bisphenol a—subacute oral toxicity study in wistar rats. Int J Environ Res Public Health. 2020;17(3):746. doi:10.3390/ijerph17030746
   PubMed Web of Science ®Google Scholar
• Landrigan P, Stegeman J, Fleming L, et al. Human health and ocean pollution. Ann Glob Health. 2020;86(1):151.
   PubMed Web of Science ®Google Scholar
• Hafezi SA, Abdel-Rahman WM. The endocrine disruptor bisphenol A (BPA) exerts a wide range of effects in carcinogenesis and response to therapy. Curr Mol Pharmacol. 2019;12(3):230. doi:10.2174/1874467212666190306164507
   PubMed Web of Science ®Google Scholar
• Filardo EJ, Thomas P. GPR30: a seven-transmembrane-spanning estrogen receptor that triggers EGF release. Trends Endocrinol Metabol. 2005;16(8):362–367. doi:10.1016/j.tem.2005.08.005
   PubMed Web of Science ®Google Scholar
• Prossnitz ER, Arterburn JB, Smith HO, et al. Estrogen signaling through the transmembrane G protein–coupled receptor GPR30. Annu Rev Physiol. 2008;70:165–190. doi:10.1146/annurev.physiol.70.113006.100518
   PubMed Web of Science ®Google Scholar
• Li Y, Chen Y, Zhu ZX, et al. 4-Hydroxytamoxifen-stimulated processing of cyclin E is mediated via G protein-coupled receptor 30 (GPR30) and accompanied by enhanced migration in MCF-7 breast cancer cells. Toxicology. 2013;309:61–65. doi:10.1016/j.tox.2013.04.012
   PubMed Web of Science ®Google Scholar
• Sukocheva O, Wadham C, Holmes A, et al. Estrogen transactivates EGFR via the sphingosine 1-phosphate receptor Edg-3: the role of sphingosine kinase-1. J Cell Biol. 2006;173(2):301–310. doi:10.1083/jcb.200506033
   PubMed Web of Science ®Google Scholar
• Zucchetti AE, Barosso IR, Boaglio AC, et al. G-protein-coupled receptor 30/adenylyl cyclase/protein kinase A pathway is involved in estradiol 17ß-d-glucuronide-induced cholestasis. Hepatology. 2014;59(3):1016–1029. doi:10.1002/hep.26752
   PubMed Web of Science ®Google Scholar
• Petrie WK, Dennis MK, Hu C, et al. G protein-coupled estrogen receptor-selective ligands modulate endometrial tumor growth. Obstet Gynecol Int. 2013;2013:472720. doi:10.1155/2013/472720
   PubMedGoogle Scholar
• Goswami C, Kuhn J, Dina OA, et al. Estrogen destabilizes microtubules through an ion-conductivity-independent TRPV1 pathway. J Neurochem. 2011;117(6):995–1008. doi:10.1111/j.1471-4159.2011.07270.x
   PubMed Web of Science ®Google Scholar
• Tica AA, Dun EC, Tica OS, et al. G protein-coupled estrogen receptor 1-mediated effects in the rat myometrium. Am J Physiol Cell Physiol. 2011;301(5):C1262–C1269. doi:10.1152/ajpcell.00501.2010
   PubMed Web of Science ®Google Scholar
• Zhou X, Wang S, Wang Z, et al. Estrogen regulates Hippo signaling via GPER in breast cancer. J Clin Invest. 2019;125(5):2123–2135. doi:10.1172/JCI79573
   Google Scholar
• Meyer MR, Clegg DJ, Prossnitz ER, et al. Obesity, insulin resistance and diabetes: sex differences and role of oestrogen receptors. Acta Physiologica. 2011;203(1):259–269. doi:10.1111/j.1748-1716.2010.02237.x
   PubMed Web of Science ®Google Scholar
• Haas E, Bhattacharya I, Brailoiu E, et al. Regulatory role of G protein–coupled estrogen receptor for vascular function and obesity. Circ Res. 2009;104(3):288–291. doi:10.1161/CIRCRESAHA.108.190892
   PubMed Web of Science ®Google Scholar
• Martensson UEA, Salehi SA, Windahl S, et al. Deletion of the G protein-coupled receptor 30 impairs glucose tolerance, reduces bone growth, increases blood pressure, and eliminates estradiol-stimulated insulin release in female mice. Endocrinology. 2009;150(2):687–698. doi:10.1210/en.2008-0623
   PubMed Web of Science ®Google Scholar
• Sharma G, Hu C, Brigman JL, et al. GPER deficiency in male mice results in insulin resistance, dyslipidemia, and a proinflammatory state. Endocrinology. 2013;154(11):4136–4145. doi:10.1210/en.2013-1357
   PubMed Web of Science ®Google Scholar
• Esposito K, Chiodini P, Colao A, et al. Metabolic syndrome and risk of cancer: a systematic review and meta-analysis. Diabetes Care. 2012;35(11):2402–2411. doi:10.2337/dc12-0336
   PubMed Web of Science ®Google Scholar
• Girgert R, Emons G, Gründker C. 17β-estradiol-induced growth of triple-negative breast cancer cells is prevented by the reduction of GPER expression after treatment with gefitinib. Oncol Rep. 2017;37(2):1212–1218. doi:10.3892/or.2016.5306
   PubMed Web of Science ®Google Scholar
• Notas G, Kampa M, Castanas E. G Protein-Coupled Estrogen Receptor in immune cells and its role in immune-related diseases. Front Endocrinol (Lausanne). 2020;11. doi:10.3389/fendo.2020.579420
   PubMed Web of Science ®Google Scholar
• Jacenik D, Beswick EJ, Krajewska WM, et al. G protein-coupled estrogen receptor in colon function, immune regulation and carcinogenesis. World J Gastroenterol. 2019;25(30):4092–4104. doi:10.3748/wjg.v25.i30.4092
   PubMed Web of Science ®Google Scholar
• Cabas I, Chaves-Pozo E, Mulero V, et al. Role of estrogens in fish immunity with special emphasis on GPER1. Dev Comp Immunol. 2018;89:102–110. doi:10.1016/j.dci.2018.08.001
   PubMed Web of Science ®Google Scholar
• Blasko E, Haskell CA, Leung S, et al. Beneficial role of the GPR30 agonist G-1 in an animal model of multiple sclerosis. J Neuroimmunol. 2009;214(1–2):67–77. doi:10.1016/j.jneuroim.2009.06.023
   PubMed Web of Science ®Google Scholar
• Wei T, Chen W, Wen L, et al. G protein-coupled estrogen receptor deficiency accelerates liver tumorigenesis by enhancing inflammation and fibrosis. Cancer Lett. 2016;382(2):195–202. doi:10.1016/j.canlet.2016.08.012
   PubMed Web of Science ®Google Scholar
• Bodhankar S, Vandenbark AA, Offner H. Oestrogen treatment of experimental autoimmune encephalomyelitis requires 17β-oestradiol-receptor-positive B cells that up-regulate PD-1 on CD 4+ Foxp3+ regulatory T cells. Immunology. 2012;137(4):282–293. doi:10.1111/imm.12013
   PubMed Web of Science ®Google Scholar
• Natale CA, Li J, Zhang J, et al. Activation of G protein-coupled estrogen receptor signaling inhibits melanoma and improves response to immune checkpoint blockade. Elife. 2018;7:e31770. doi:10.7554/eLife.31770
   PubMed Web of Science ®Google Scholar
• Natale CA, Li J, Pitarresi JR, et al. Pharmacologic activation of the G protein-coupled estrogen receptor inhibits pancreatic ductal adenocarcinoma. Cell Mol Gastroenterol Hepatol. 2020;10:868–880.e1. doi:10.1016/j.jcmgh.2020.04.016
   PubMed Web of Science ®Google Scholar
• Torre LA, Bray FI, Siegel RL, et al. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87–108. doi:10.3322/caac.21262
   PubMed Web of Science ®Google Scholar
• Biagioni A, Skalamera I, Peri S, et al. Update on gastric cancer treatments and gene therapies. Cancer Metastasis Rev. 2019;38(3):537–548. doi:10.1007/s10555-019-09803-7
   PubMed Web of Science ®Google Scholar
• Tan Z. Recent advances in the surgical treatment of advanced gastric cancer: a review. Med Sci Monit. 2019;25:3537–3541. doi:10.12659/MSM.916475
   PubMed Web of Science ®Google Scholar
• Tian S, Zhan N, Li R, et al. Downregulation of G Protein-Coupled Estrogen Receptor (GPER) is associated with reduced prognosis in patients with gastric cancer. Med Sci Monit. 2019;25:3115–3126. doi:10.12659/MSM.913634
   PubMed Web of Science ®Google Scholar
• Lee SJ, Kim TW, Park GL, et al. G protein-coupled estrogen receptor-1 agonist induces chemotherapeutic effect via ER stress signaling in gastric cancer. BMB Rep. 2019;52(11):647–652. doi:10.5483/BMBRep.2019.52.11.007
   PubMed Web of Science ®Google Scholar
• Zheng S, Yang L, Dai Y, et al. Screening and survival analysis of hub genes in gastric cancer based on bioinformatics. J Comp Biol. 2019;26(11):1316–1325. doi:10.1089/cmb.2019.0119
   PubMed Web of Science ®Google Scholar
• Akinyemiju T, Abera S, Ahmed M, et al. The burden of primary liver cancer and underlying etiologies from 1990 to 2015 at the global, regional, and national level: results from the Global Burden of Disease Study 2015. JAMA Oncol. 2017;3(12):1683–1691. doi:10.1001/jamaoncol.2017.3055
   PubMed Web of Science ®Google Scholar
• El–Serag HB, Rudolph KL. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology. 2007;132(7):2557–2576. doi:10.1053/j.gastro.2007.04.061
   PubMed Web of Science ®Google Scholar
• Zhang Y, Ren JS, Shi JF, et al. International trends in primary liver cancer incidence from 1973 to 2007. BMC Cancer. 2015;15(1):94. doi:10.1186/s12885-015-1113-4
   PubMedGoogle Scholar
• Kur P, Kolasa-Wołosiuk A, Misiakiewicz-Has K, et al. Sex hormone-dependent physiology and diseases of liver. Int J Environ Res Public Health. 2020;17(8):2620. doi:10.3390/ijerph17082620
   PubMed Web of Science ®Google Scholar
• Sukocheva OA. Estrogen, estrogen receptors, and hepatocellular carcinoma: are we there yet? World J Gastroenterol. 2018;24(1):1–4. doi:10.3748/wjg.v24.i1.1
   PubMed Web of Science ®Google Scholar
• Przybyszewska J, Żekanowska E. The role of hepcidin, ferroportin, HCP1, and DMT1 protein in iron absorption in the human digestive tract. Przeglad Gastroenterol. 2014;9(4):208. doi:10.5114/pg.2014.45102
   PubMedGoogle Scholar
• Ikeda Y, Tajima S, Izawa-Ishizawa Y, et al. Estrogen regulates hepcidin expression via GPR30-BMP6-dependent signaling in hepatocytes. PLoS One. 2012;7(7):e40465. doi:10.1371/journal.pone.0040465
   PubMed Web of Science ®Google Scholar
• Ulitzky L, Lafer MM, KuKuruga MA, et al. A new signaling pathway for HCV inhibition by estrogen: GPR30 activation leads to cleavage of occludin by MMP-9. PLoS One. 2016;11(1):e0145212. doi:10.1371/journal.pone.0145212
   PubMed Web of Science ®Google Scholar
• Cortes E, Lachowski D, Rice A, et al. Tamoxifen mechanically deactivates hepatic stellate cells via the G protein-coupled estrogen receptor. Oncogene. 2019;38(16):2910–2922. doi:10.1038/s41388-018-0631-3
   PubMed Web of Science ®Google Scholar
• Shen M, Shi H, Migliaccio A. Estradiol and estrogen receptor agonists oppose oncogenic actions of leptin in HepG2 cells. PLoS One. 2016;11(3):e0151455. doi:10.1371/journal.pone.0151455
   PubMed Web of Science ®Google Scholar
• Chaturantabut S, Shwartz A, Evason KJ, et al. Estrogen activation of G-protein–coupled estrogen receptor 1 regulates phosphoinositide 3-kinase and mTOR signaling to promote liver growth in zebrafish and proliferation of human hepatocytes. Gastroenterology. 2019;156(6):1788–1804. e13. doi:10.1053/j.gastro.2019.01.010
   PubMed Web of Science ®Google Scholar
• Teng Y, Radde BN, Litchfield LM, et al. Dehydroepiandrosterone activation of G-protein-coupled estrogen receptor rapidly stimulates microRNA-21 transcription in human hepatocellular carcinoma cells. J Biol Chem. 2015;290(25):15799–15811. doi:10.1074/jbc.M115.641167
   PubMed Web of Science ®Google Scholar
• Kuhajda FP. Fatty acid synthase and cancer: new application of an old pathway. Cancer Res. 2006;66(12):5977–5980. doi:10.1158/0008-5472.CAN-05-4673
   PubMed Web of Science ®Google Scholar
• Santolla MF, Lappano R, De Marco P, et al. G protein-coupled estrogen receptor mediates the up-regulation of fatty acid synthase induced by 17β-estradiol in cancer cells and cancer-associated fibroblasts. J Biol Chem. 2012;287(52):43234–43245. doi:10.1074/jbc.M112.417303
   PubMed Web of Science ®Google Scholar
• Baldissera VD, Alves AF, Almeida S, et al. Hepatocellular carcinoma and estrogen receptors: polymorphisms and isoforms relations and implications. Med Hypotheses. 2016;86:67–70. doi:10.1016/j.mehy.2015.11.030
   PubMed Web of Science ®Google Scholar
• Rahib L, Smith BD, Aizenberg R, et al. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res. 2014;74(11):2913–2921. doi:10.1158/0008-5472.CAN-14-0155
   PubMed Web of Science ®Google Scholar
• Andersson G, Borgquist S, Jirstrom K. Hormonal factors and pancreatic cancer risk in women: the Malmö Diet and Cancer Study. Int J Cancer. 2018;143(1):52–62. doi:10.1002/ijc.31302
   PubMed Web of Science ®Google Scholar
• Mesmar F, Dai B, Ibrahim AF, et al. Clinical candidate and genistein analogue AXP107-11 has chemoenhancing functions in pancreatic adenocarcinoma through G protein-coupled estrogen receptor signaling. Cancer Med. 2019;8(18):7705–7719. doi:10.1002/cam4.2581
   PubMed Web of Science ®Google Scholar
• Rice A, Cortes E, Lachowski D, et al. GPER activation inhibits cancer cell mechanotransduction and basement membrane invasion via RhoA. Cancers. 2020;12(2):289. doi:10.3390/cancers12020289
   PubMed Web of Science ®Google Scholar
• Erkan M, Hausmann S, Michalski CW, et al. The role of stroma in pancreatic cancer: diagnostic and therapeutic implications. Nat Rev Gastroenterol Hepatol. 2012;9(8):454–467. doi:10.1038/nrgastro.2012.115
   PubMed Web of Science ®Google Scholar
• Cortes E, Lachowski D, Robinson B, et al. Tamoxifen mechanically reprograms the tumor microenvironment via HIF-1A and reduces cancer cell survival. EMBO Rep. 2019;20(1):e46557. doi:10.15252/embr.201846557
   PubMed Web of Science ®Google Scholar
• Cortes E, Sarper M, Robinson B, et al. GPER is a mechanoregulator of pancreatic stellate cells and the tumor microenvironment. EMBO Rep. 2019;20(1):e46556. doi:10.15252/embr.201846556
   PubMed Web of Science ®Google Scholar
• Barzi A, Lenz AM, Labonte MJ, et al. Molecular pathways: estrogen pathway in colorectal cancer. Clin Cancer Res. 2013;19(21):5842–5848. doi:10.1158/1078-0432.CCR-13-0325
   PubMed Web of Science ®Google Scholar
• Liu Q, Chen Z, Jiang G, et al. Epigenetic down regulation of G protein-coupled estrogen receptor (GPER) functions as a tumor suppressor in colorectal cancer. Mol Cancer. 2017;16(1):87. doi:10.1186/s12943-017-0654-3
   PubMedGoogle Scholar
• Konstantinopoulos PA, Kominea A, Vandoros G, et al. Oestrogen receptor beta (ERβ) is abundantly expressed in normal colonic mucosa, but declines in colon adenocarcinoma paralleling the tumour’s dedifferentiation. Eur J Cancer. 2003;39(9):1251–1258. doi:10.1016/S0959-8049(03)00239-9
   PubMed Web of Science ®Google Scholar
• Rudolph A, Toth C, Hoffmeister M, et al. Expression of oestrogen receptor β and prognosis of colorectal cancer. Br J Cancer. 2012;107(5):831–839. doi:10.1038/bjc.2012.323
   PubMed Web of Science ®Google Scholar
• Bustos V, Nolan ÁM, Nijhuis A, et al. GPER mediates differential effects of estrogen on colon cancer cell proliferation and migration under normoxic and hypoxic conditions. Oncotarget. 2017;8(48):84258–84275. doi:10.18632/oncotarget.20653
   PubMedGoogle Scholar
• Gilligan LC, Gondal A, Tang V, et al. Estrone sulfate transport and steroid sulfatase activity in colorectal cancer: implications for hormone replacement therapy. Front Pharmacol. 2017;8:103. doi:10.3389/fphar.2017.00103
   PubMed Web of Science ®Google Scholar
• Gilligan LC, Rahman HP, Hewitt AM, et al. Estrogen activation by steroid sulfatase increases colorectal cancer proliferation via GPER. J Clin Endocrinol Metab. 2017;102(12):4435–4447. doi:10.1210/jc.2016-3716
   PubMed Web of Science ®Google Scholar